Biocon Refutes Graft Charges After Regulatory Official Booked, Says Due Process Followed

Expert Panel Trial Waiver Endorsement Came In May

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".